EP4083627 - PROGNOSTIC BIOMARKER OF CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 30.09.2022 Database last updated on 31.08.2024 | |
Former | The international publication has been made Status updated on 07.07.2021 | Most recent event Tooltip | 06.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Hoshi General Hospital, a Public Interest Incorporated Foundation 159-1, Mukaigawara-machi Koriyama-shi, Fukushima 963-8501 / JP | For all designated states Homma, Miwako c/o Fukushima Medical University 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | For all designated states Homma, Yoshimi c/o Fukushima Medical University 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | For all designated states Hashimoto, Yuko c/o Fukushima Medical University 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | [2022/44] | Inventor(s) | 01 /
NOMIZU Tadashi c/o Hoshi General Hospital, a public interest incorporated foundation, 159-1, Mukaigawara-machi Koriyama-shi, Fukushima 963-8501 / JP | 02 /
KIKO Yuichiro c/o Fukushima Medical University, 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | 03 /
HOMMA Miwako c/o Fukushima Medical University, 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | 04 /
HOMMA Yoshimi c/o Fukushima Medical University, 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | 05 /
HASHIMOTO Yuko c/o Fukushima Medical University, 1, Hikarigaoka Fukushima-shi, Fukushima 960-1295 / JP | [2022/44] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2022/44] | Application number, filing date | 20904709.1 | 25.12.2020 | [2022/44] | WO2020JP48650 | Priority number, date | JP20190234099 | 25.12.2019 Original published format: JP 2019234099 | [2022/44] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021132544 | Date: | 01.07.2021 | Language: | JA | [2021/26] | Type: | A1 Application with search report | No.: | EP4083627 | Date: | 02.11.2022 | Language: | EN | [2022/44] | Search report(s) | International search report - published on: | JP | 01.07.2021 | (Supplementary) European search report - dispatched on: | EP | 14.12.2023 | Classification | IPC: | G01N33/574, C07K14/47, C12Q1/02, C12N9/12 | [2024/03] | CPC: |
G01N33/57415 (EP,US);
C12N9/12 (EP,US);
C12Y207/11001 (EP,US);
G01N33/57496 (EP);
G01N33/68 (US);
G01N2333/9121 (EP,US);
|
Former IPC [2022/44] | G01N33/574, C07K14/47, C12Q1/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/44] | Title | German: | PROGNOSTISCHER BIOMARKER VON KREBS | [2022/44] | English: | PROGNOSTIC BIOMARKER OF CANCER | [2022/44] | French: | BIOMARQUEUR DE PRONOSTIC DU CANCER | [2022/44] | Entry into regional phase | 05.07.2022 | Translation filed | 05.07.2022 | National basic fee paid | 05.07.2022 | Search fee paid | 05.07.2022 | Designation fee(s) paid | 05.07.2022 | Examination fee paid | Examination procedure | 05.07.2022 | Examination requested [2022/44] | 05.07.2024 | Amendment by applicant (claims and/or description) | 05.07.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 05.07.2022 | Renewal fee patent year 03 | 20.12.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]EP2472263 (COMMISSARIAT ENERGIE ATOMIQUE [FR]) [X] 11 * paragraph [0033]; claims 1,11-15 * [Y] 1-11 [I] 1-10; | [A] - LARAMAS ET AL, "Nuclear localization of protein kinase CK2 catalytic subunit (CK2@a) is associated with poor prognostic factors in human prostate cancer", EUROPEAN JOURNAL OF CANCER, ELSEVIER, AMSTERDAM NL, (20070316), vol. 43, no. 5, doi:10.1016/J.EJCA.2006.11.021, ISSN 0959-8049, pages 928 - 934, XP005919065 [A] 1-10 * abstract * DOI: http://dx.doi.org/10.1016/j.ejca.2006.11.021 | [A] - FAUST R A ET AL, "Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells", INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, ELSEVIER, AMSTERDAM, NL, (19990901), vol. 31, no. 9, doi:10.1016/S1357-2725(99)00050-3, ISSN 1357-2725, pages 941 - 949, XP002437111 [A] 1-10 * abstract * DOI: http://dx.doi.org/10.1016/S1357-2725(99)00050-3 | [Y] - BESTGEN BENOÎT ET AL, "2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action", JOURNAL OF MEDICINAL CHEMISTRY, US, (20190228), vol. 62, no. 4, doi:10.1021/acs.jmedchem.8b01765, ISSN 0022-2623, pages 1817 - 1836, XP055793780 [Y] 1-11 * abstract * * page 1827, column 2, paragraph 2 * DOI: http://dx.doi.org/10.1021/acs.jmedchem.8b01765 | [Y] - PFAFF M ET AL, "Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation", BIOCHIMICA ET BIOPHYSICA ACTA, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 969, no. 1, doi:10.1016/0167-4889(88)90093-6, ISSN 0167-4889, (19880402), pages 100 - 109, (19880402), XP025464516 [Y] 1-11 * abstract * DOI: http://dx.doi.org/10.1016/0167-4889(88)90093-6 | International search | [A]WO2005113835 (UNIV NORTHEASTERN [US], et al) [A] 1-11; | [A]WO2008083998 (INST NAT SANTE RECH MED [FR], et al) [A] 1-11; | [A]EP2472263 (COMMISSARIAT ENERGIE ATOMIQUE [FR]) [A] 1-11; | [A]US2013230852 (YOU LIANG [US], et al) [A] 1-11; | [PX] - KATO HOMMA MIWAKO et al., "Intracellular localization of CK2a as a prognostic factor in invasive breast carcinomas", Cancer Science, (20201108), vol. 112, no. 2, pages 619 - 628, XP055839400 [PX] 1-11 * Abstract * DOI: http://dx.doi.org/10.1111/cas.14728 | by applicant | - ROSS J.S. et al., Oncologist, (20030000), vol. 8, no. 4, pages 307 - 25 | - ALTSCHUL et al., Nuc. Acids. Res., (19770000), vol. 25, pages 3389 - 3402 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410 | - "TNM Classification of Malignant Tumours", UICC INTERNATIONAL CODEL.H. SOBINM.K. GOSPODAROWICZCH. WITTEKIND, TNM Classification of Malignant Tumours, Union for International Cancer Control | JP20190234099 |